See All Slides - tctmd.com

Slides

Presentation TCT 2015

Rivaroxaban: Analysis of Efficacy, Safety, and Special Considerations

Presenter: Lisa K. Jennings, Matthew T. Roe, Manesh R. Patel

October 14, 2015

Presentation TCT 2015

Update on the ROPE Study: Emerging Insights

Presenter: John D. Carroll, Mark Reisman, David E. Thaler

October 14, 2015

Presentation TCT 2015

Has the Proximal Optimization Technique (POT) Become Essential? Heres Why

Presenter: Antonio L. Bartorelli, Yves R. Louvard, Massoud A. Leesar

October 14, 2015

Presentation TCT 2015

BRS Mechanical Properties, Conformability, and Other Insights From Bench Studies

Presenter: Elazer R. Edelman, Juan F. Granada, Nicolas Foin

October 14, 2015

Presentation TCT 2015

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time!

Presenter: William A. Gray, D. Christopher Metzger, Gary S. Roubin

October 14, 2015

Presentation TCT 2015

ASD After MitraClip: Is This the Smoking Gun?

Presenter: Stephan Baldus, Saibal Kar, Michael J. Lim

October 14, 2015

Presentation TCT 2015

Evidence Review: Revascularization in LV Dysfunction After STICH Who Might Benefit?

Presenter: Robert O. Bonow, Ajay J. Kirtane

October 14, 2015

Presentation TCT 2015

Impulse Dynamics

Presenter: Daniel Burkhoff, Ileana L. Pina, William T. Abraham

October 14, 2015

Presentation TCT 2015

TUXEDO: A Prospective Randomized Trial of Paclitaxel-Eluting vs Everolimus-Eluting Stents in Diabetic Patients With Coronary Artery Disease

Presenter: Cindy L. Grines, Upendra Kaul

October 14, 2015

Presentation TCT 2015

FDA-Approved or US IDE Studies: SAPIEN 3 Procedural Considerations and Case Examples

Presenter: Ariel Finkelstein, Ganesh Manoharan, Vinod H. Thourani

October 14, 2015

Advertisement

Slides

Rivaroxaban: Analysis of Efficacy, Safety, and Special Considerations

Update on the ROPE Study: Emerging Insights

Has the Proximal Optimization Technique (POT) Become Essential? Heres Why

BRS Mechanical Properties, Conformability, and Other Insights From Bench Studies

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time!

ASD After MitraClip: Is This the Smoking Gun?

Evidence Review: Revascularization in LV Dysfunction After STICH Who Might Benefit?

Impulse Dynamics

TUXEDO: A Prospective Randomized Trial of Paclitaxel-Eluting vs Everolimus-Eluting Stents in Diabetic Patients With Coronary Artery Disease

FDA-Approved or US IDE Studies: SAPIEN 3 Procedural Considerations and Case Examples

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content